Magenta Medical Secures Funding for Development of Therapies for Acute Heart Failure


September 28, 2017—Magenta Medical, an Israel-based company developing therapeutic approaches to the management and treatment of acute heart failure, announced the closing of its $15 million Series B financing round. The funding will support the expansion and acceleration of the clinical program toward approval in Europe and a pivotal study in the United States.

The syndicate of investors is comprised of Abiomed, Inc., as well as Pitango Venture Capital, JAFCO Co. Ltd., and a group of industry leaders and cardiovascular experts led by Prof. Jacques Seguin, MD, who is joining Magenta's Board of Directors after the closing. Magenta Medical was founded in October 2012 by Prof. Ehud Schwammenthal, MD, and Yosi Tuval.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.